Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold

NCT03587922 is registered in ClinicalTrials.gov with REVA Medical, Inc. as lead sponsor.

NCT NCT03587922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03587922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold
Lead sponsor
REVA Medical, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
May 1, 2018
Completion date
May 1, 2025
Enrollment
1,500 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease